Founded in 1996, Maxivision is one of India’s leading and fastest-growing private eye care clinics. It operates 50 centres in five states across South and West India, including Telangana, Andhra Pradesh, Gujarat, Kerala, and Tamil Nadu. The company offers a full suite of neonatal, paediatric, and geriatric eye care services, including cataract surgery, LASIK and ReLEx Smile treatments, treatments for retinal issues and glaucoma, and oculoplasty.
SINGAPORE, September 27, 2024. Quadria Capital (“Quadria”), one of Asia’s largest healthcare-focused private equity firms, today announced that it has been awarded “PE Deal of the Year” by the Singapore Venture & Private Capital Association (“SVCA”) for the second year in a row in recognition of its investment in Maxivision Eye Hospital (“Maxivision”).
Founded in 1996, Maxivision is one of India’s leading and fastest-growing private eye care clinics. It operates 50 centres in five states across South and West India, including Telangana, Andhra Pradesh, Gujarat, Kerala, and Tamil Nadu. The company offers a full suite of neonatal, paediatric, and geriatric eye care services, including cataract surgery, LASIK and ReLEx Smile treatments, treatments for retinal issues and glaucoma, and oculoplasty.
Sunil Thakur, Partner and Head of South Asia at Quadria Capital, said: “Since our firm’s founding in 2013, we have been investing in a changing healthcare landscape, backing entrepreneurs and working closely with them to help grow successful companies. We are truly honoured to receive the Deal of the Year award for our investment in Maxivision. This accolade is a testament to the exceptional dedication and expertise of our team, as well as the unwavering support from our partners and investors. We are excited to continue advancing our mission of transforming healthcare in the region through ongoing collaborations with visionary leaders.”
Abhishek Yadav, Managing Director at Quadria Capital, said: “We are pleased to receive this esteemed award from SVCA in recognition of our investment in Maxivision. This honour highlights Quadria’s longstanding expertise in identifying and leveraging emerging healthcare trends, and the firm’s investments in businesses that aim to bring quality and affordable treatments to underserved populations. Maxivision is engaged in incredible work to expand access to quality eye care, and we are thrilled to be partnering with them as they embark on the next phase of their growth journey.”
Drawing on its extensive network and industry experience, Quadria is well-equipped to offer significant strategic guidance to Maxivision. Through financial backing and deep sector expertise, Quadria aims to help Maxivision reach its stated goal of operating 100 facilities to capitalise on the growth of the Indian eye care market, which is expected to expand at over 15% per year over the next five years.
Hosted by SVCA, the annual awards honour exceptional contributions within the private equity and venture capital sector in the Asia-Pacific region and highlight the achievements and value generated through key investments.
About Quadria Capital
Founded in 2012, Quadria is an Asia healthcare-focused private equity firm with assets under management of over US$3.5 billion, maximising returns by investing in the high growth healthcare sector of some of the world’s fastest-growing economies in South Asia and Southeast Asia, including Healthcare Delivery, Life Sciences, Medical Technology and Associated Healthcare Services subsectors. The firm aims to create significant and sustainable shareholder value by supporting strong, professionally run, stable and scalable healthcare organisations to address the critical and undersupplied healthcare needs in Asia.
For more information, please visit www.quadriacapital.com
Investor Relations Contact
Gerald Ng, Head of Investor Relations
Email: [email protected]